Guangdong Zhongsheng Pharmaceutical Co., Ltd. (SHE:002317)

SHE:002317 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	932.32	1,399	1,252	927.67	1,016	1,324
Short-Term Investments	107.77	163.69	389.1	151.75	40	-
Trading Asset Securities	342.12	305.99	683.06	340.68	239.92	306.65
Cash & Short-Term Investments	1,382	1,869	2,324	1,420	1,296	1,630
Cash Growth	-10.22%	-19.58%	63.66%	9.55%	-20.49%	68.09%
Accounts Receivable	1,218	999.6	978.3	1,204	792.46	955.56
Other Receivables	8.66	55.85	45.62	29.44	11.48	11.36
Receivables	1,227	1,055	1,024	1,233	803.94	966.93
Inventory	349.16	441.48	520.39	481.06	452.2	403.83
Prepaid Expenses	-	-	-	-	0	-
Other Current Assets	140.8	96.74	92.1	100.4	119.12	132.26
Total Current Assets	3,099	3,463	3,961	3,235	2,672	3,133
Property, Plant & Equipment	728.07	687.36	695.91	636.82	601.24	557.97
Long-Term Investments	145.14	516.23	519.95	727.09	650.61	164.88
Goodwill	6.95	6.95	208.63	208.63	208.63	208.63
Other Intangible Assets	517.06	327.11	446.7	260.4	261.28	268.09
Long-Term Deferred Tax Assets	21.19	29.69	42.45	47.03	46.89	36.87
Long-Term Deferred Charges	332.08	489.91	564.31	586.61	401.03	335.77
Other Long-Term Assets	318.15	33.44	19.97	74.15	60.76	70.58
Total Assets	5,167	5,553	6,459	5,775	4,902	4,776
Accounts Payable	90.91	93.1	93.78	126.28	106.7	88.78
Accrued Expenses	19.38	141.86	163.32	232.01	164.43	182.51
Short-Term Debt	402.71	303.46	621.49	587.6	190	481
Current Portion of Long-Term Debt	-	-	2.09	22	12	10
Current Portion of Leases	127.17	1.66	2.72	2.55	1.71	-
Current Income Taxes Payable	50.94	4.92	12.46	13.61	1.51	0.94
Current Unearned Revenue	21.18	20.08	25.91	45.24	18.85	25.96
Other Current Liabilities	117.93	638.39	93.54	79.04	29	30.38
Total Current Liabilities	830.22	1,203	1,015	1,108	524.2	819.57
Long-Term Debt	-	-	97	286	308	225
Long-Term Leases	6.45	0.3	1.3	4.02	5.27	-
Long-Term Unearned Revenue	154.64	161.94	132.67	55.57	32.74	39.44
Long-Term Deferred Tax Liabilities	38.06	38.9	48.95	70.23	59.96	65.58
Other Long-Term Liabilities	12.14	138.76	637.61	434.68	433.67	-
Total Liabilities	1,042	1,543	1,933	1,959	1,364	1,150
Common Stock	849.93	851.56	853.35	814.43	814.46	814.46
Additional Paid-In Capital	1,815	1,780	1,807	1,310	1,321	1,466
Retained Earnings	1,317	1,237	1,706	1,604	1,444	1,327
Treasury Stock	-	-8.1	-67.14	-80.36	-151.6	-100.01
Comprehensive Income & Other	48.27	54.86	57.36	54.45	47.52	18.04
Total Common Equity	4,030	3,915	4,356	3,703	3,476	3,525
Minority Interest	95.86	95.34	169.37	113.72	62.49	101.51
Shareholders' Equity	4,126	4,010	4,526	3,816	3,538	3,626
Total Liabilities & Equity	5,167	5,553	6,459	5,775	4,902	4,776
Total Debt	536.33	305.43	724.6	902.17	516.98	716
Net Cash (Debt)	845.87	1,564	1,600	517.93	779.3	914.29
Net Cash Growth	-44.99%	-2.24%	208.85%	-33.54%	-14.76%	1109.04%
Net Cash Per Share	1.01	1.88	1.94	0.64	0.98	1.14
Filing Date Shares Outstanding	849.93	846.01	847.8	808.88	797.43	802.99
Total Common Shares Outstanding	849.93	846.01	847.8	808.88	797.43	803.36
Working Capital	2,269	2,259	2,945	2,126	2,147	2,314
Book Value Per Share	4.74	4.63	5.14	4.58	4.36	4.39
Tangible Book Value	3,506	3,581	3,701	3,234	3,006	3,048
Tangible Book Value Per Share	4.13	4.23	4.37	4.00	3.77	3.79
Buildings	-	561.69	527.39	506.28	474.51	460.07
Machinery	-	734.13	638.4	600.95	568.8	531.19
Construction In Progress	-	27.58	123.55	82.03	56.47	22.99

Source: S&P Global Market Intelligence. Standard template. Financial Sources.